Vitamin D3 lactone derivative

Details for Australian Patent Application No. 2004207719 (hide)

Owner Teijin Pharma Limited

Inventors Ishizuka, Seiichi; Saito, Hiroshi; Miura, Daishiro; Saito, Nozomi; Takenouchi, Kazuya; Anzai, Miyuki; Okada, Kazuhisa; Fujishima, Toshie; Kittaka, Atsushi; Takayama, Hiroaki

Agent Davies Collison Cave

Pub. Number AU-B-2004207719

PCT Pub. Number WO2004/067525

Priority 2003-021650 30.01.03 JP; 2003-339658 30.09.03 JP

Filing date 29 January 2004

Wipo publication date 12 August 2004

Acceptance publication date 6 August 2009

International Classifications

C07D 307/58 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 3/14 (2006.01) Drugs for disorders of the metabolism

A61P 5/18 (2006.01) Drugs for disorders of the endocrine system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 17/10 (2006.01) Drugs for dermatological disorders

A61P 17/14 (2006.01) Drugs for dermatological disorders

Event Publications

4 August 2005 PCT application entered the National Phase

  PCT publication WO2004/067525 Priority application(s): WO2004/067525

6 August 2009 Application Accepted

  Published as AU-B-2004207719

3 December 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004207720-Crystal of (23S)-1alpha-hydroxy-27-nor-25-methyl enevitamin D3-26,23-lactone and process for producing the same

2004207706-Thienopyrimidine compounds and use thereof